Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liverWenshu Tang, Alfred S.L. Cheng, Haoran Wu et al.|Cellular and Molecular Immunology|2022Cited by 112
Prospective double-blinded randomized controlled trial of Microwave versus RadioFrequency Ablation for hepatocellular carcinoma (McRFA trial)Charing C. N. Chong, Paul B.S. Lai, Kit F. Lee et al.|HPB|2020Cited by 73